NU17CE010204
Cooperative Agreement
Overview
Grant Description
Overdose Data to Action-States - Abstract: Missouri’s efforts under the Overdose Data to Action (OD2A) Cooperative Agreement will achieve CDC’s desired outcomes related to enhancing Missouri’s ability to track and prevent nonfatal and fatal overdoses while identifying emerging threats.
Progress toward these outcomes will be accomplished through opioid surveillance enhancements, prevention interventions to increase awareness of opioid misuse and link individuals to substance use disorder treatment, and dissemination of findings to inform ongoing interventions.
Missouri’s proposed activities have been developed based on available surveillance data and include an emphasis on services that can be tailored to address the needs of the population of focus.
Missouri’s activities within OD2A will achieve the following outcomes by the end of the project period:
- Strategy 1 Outcomes:
* More timely, detailed, comprehensive, and actionable surveillance for nonfatal overdoses.
* Increased data sharing and data availability.
* Increased data dissemination.
* Expanded use of data to inform the implementation and improvement of prevention and response efforts, especially for groups disproportionately affected by overdose.
* Continued operational capabilities for performance of laboratory analysis of fentanyl surveillance samples collected from overdose patients.
- Strategy 2 Outcomes:
* Expanded use of data to inform the implementation and improvement of prevention and response efforts, especially for groups disproportionately affected by overdose.
- Strategy 3 Outcomes:
* Expanded use of data to inform the implementation and improvement of prevention and response efforts, especially for groups disproportionately affected by overdose.
- Strategy 4 Outcomes:
* Increased collaboration, coordination, and communication among partners.
* Using a validated method, collect and perform definitive toxicological analyses on specimens from overdose patients around Missouri.
* Primary targets of analysis will be fentanyl and fentanyl analogs, with flexibility to add additional analytes as needed.
* Data collected to detect usage trends thereby increasing effectiveness of both prevention and treatment strategies.
* Data used to create data products to be employed for educating public, caregiver, and prevention partners; designing future work plans and strategies; and retrospectively evaluating existing strategies.
- Strategy 5 Outcomes:
* Expanded use of data to inform the implementation and improvement of prevention and response efforts, especially for groups disproportionately affected by overdose.
* Improved identification of factors contributing to overdose using linked data sets.
- Strategy 6 Outcomes:
* Increased clinician awareness of evidence-based practices for pain management.
* Increased clinician expertise and confidence to provide equitable OUD and STI care.
* Increased and improved access to PDMPS.
* Increased use of navigators to link PWUD to care and services.
* Increased linkages to care and engagement in care across various settings.
- Strategy 7 Outcomes:
Increased awareness of the drug overdose epidemic, harm reduction efforts, and evidence-based approaches.
* Increased availability of and decreased barriers to care/services, especially for those disproportionately affected by overdose and those previously underserved by overdose prevention programs and the healthcare system.
- Strategy 8 Outcomes:
* Increased collaboration, coordination, and communication among partners.
* Increased use of navigators to link PWUD to care and services.
* Increased access to harm reduction education and services, including increased distribution of naloxone.
- Strategy 9 Outcomes:
* Increased use of navigators to link PWUD to care and services.
Progress toward these outcomes will be accomplished through opioid surveillance enhancements, prevention interventions to increase awareness of opioid misuse and link individuals to substance use disorder treatment, and dissemination of findings to inform ongoing interventions.
Missouri’s proposed activities have been developed based on available surveillance data and include an emphasis on services that can be tailored to address the needs of the population of focus.
Missouri’s activities within OD2A will achieve the following outcomes by the end of the project period:
- Strategy 1 Outcomes:
* More timely, detailed, comprehensive, and actionable surveillance for nonfatal overdoses.
* Increased data sharing and data availability.
* Increased data dissemination.
* Expanded use of data to inform the implementation and improvement of prevention and response efforts, especially for groups disproportionately affected by overdose.
* Continued operational capabilities for performance of laboratory analysis of fentanyl surveillance samples collected from overdose patients.
- Strategy 2 Outcomes:
* Expanded use of data to inform the implementation and improvement of prevention and response efforts, especially for groups disproportionately affected by overdose.
- Strategy 3 Outcomes:
* Expanded use of data to inform the implementation and improvement of prevention and response efforts, especially for groups disproportionately affected by overdose.
- Strategy 4 Outcomes:
* Increased collaboration, coordination, and communication among partners.
* Using a validated method, collect and perform definitive toxicological analyses on specimens from overdose patients around Missouri.
* Primary targets of analysis will be fentanyl and fentanyl analogs, with flexibility to add additional analytes as needed.
* Data collected to detect usage trends thereby increasing effectiveness of both prevention and treatment strategies.
* Data used to create data products to be employed for educating public, caregiver, and prevention partners; designing future work plans and strategies; and retrospectively evaluating existing strategies.
- Strategy 5 Outcomes:
* Expanded use of data to inform the implementation and improvement of prevention and response efforts, especially for groups disproportionately affected by overdose.
* Improved identification of factors contributing to overdose using linked data sets.
- Strategy 6 Outcomes:
* Increased clinician awareness of evidence-based practices for pain management.
* Increased clinician expertise and confidence to provide equitable OUD and STI care.
* Increased and improved access to PDMPS.
* Increased use of navigators to link PWUD to care and services.
* Increased linkages to care and engagement in care across various settings.
- Strategy 7 Outcomes:
Increased awareness of the drug overdose epidemic, harm reduction efforts, and evidence-based approaches.
* Increased availability of and decreased barriers to care/services, especially for those disproportionately affected by overdose and those previously underserved by overdose prevention programs and the healthcare system.
- Strategy 8 Outcomes:
* Increased collaboration, coordination, and communication among partners.
* Increased use of navigators to link PWUD to care and services.
* Increased access to harm reduction education and services, including increased distribution of naloxone.
- Strategy 9 Outcomes:
* Increased use of navigators to link PWUD to care and services.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
Missouri
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 200% from $4,394,497 to $13,183,491.
Missouri Department Of Health And Senior Services was awarded
OD2A Grant: Enhancing Overdose Data for Prevention
Cooperative Agreement NU17CE010204
worth $13,183,491
from Injury Center in September 2023 with work to be completed primarily in Missouri United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.136 Injury Prevention and Control Research and State and Community Based Programs.
The Cooperative Agreement was awarded through grant opportunity Overdose Data to Action in States.
Status
(Ongoing)
Last Modified 9/5/25
Period of Performance
9/1/23
Start Date
8/31/28
End Date
Funding Split
$13.2M
Federal Obligation
$0.0
Non-Federal Obligation
$13.2M
Total Obligated
Activity Timeline
Transaction History
Modifications to NU17CE010204
Additional Detail
Award ID FAIN
NU17CE010204
SAI Number
NU17CE010204-3505534819
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CUH0 CDC NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL
Awardee UEI
UETLXV8NG8F4
Awardee CAGE
3A4D6
Performance District
MO-90
Senators
Joshua Hawley
Eric Schmitt
Eric Schmitt
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Injury Prevention and Control, Centers for Disease Control and Prevention, Health and Human Services (075-0952) | Health care services | Grants, subsidies, and contributions (41.0) | $4,394,497 | 100% |
Modified: 9/5/25